Rhinitis of Pregnancy and Hormonally Induced Rhinitis
摘要
To provide a comprehensive overview of the etiology, pathophysiology, clinical presentation, diagnosis, and management of these conditions, with a primary focus on rhinitis of pregnancy.
Recent FindingsRhinitis of pregnancy occurs in approximately 20–30% of pregnant women, usually occurring during the second trimester, and with symptom resolution postpartum. Elevated levels of estrogen and progesterone enhance nasal vascularity and mucosal edema. The diagnosis is primarily clinical, with limited utility for imaging or other diagnostic tests. Management strategies focus on symptom relief. Treatment options are primarily conservative, which include nasal saline irrigation, alongside careful selection of pharmacological treatments that are safe in pregnancy. Despite its prevalence, rhinitis of pregnancy is under-recognized, and more research is needed to fully understand its implications and optimal management.
SummaryRhinitis of pregnancy is a distinct clinical entity with significant implications for maternal well-being. Increased awareness and appropriate management are important for enhancing quality of life for pregnant women. Future research should focus on pathophysiology, improving diagnostic criteria, and developing targeted therapies that are safe and effective during pregnancy.